Cell signaling via the P2X7 nucleotide receptor: Linkage to ROS production, gene transcription, and receptor trafficking

Purinergic Signalling

Volumn 5, Issue 2, 2009, Pages 175-187

  Lenertz, Lisa Y ^a   Gavala, Monica L ^a   Hill, Lindsay M ^a   Bertics, Paul J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

AP 1; Arg based ER retention signals; CREB; Mediator production; P2X7; ROS

Indexed keywords

EID: 67349098560     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-009-9133-7     Document Type: Article

References (105)

1. Vassort G (2001) Adenosine 5′-triphosphate: A P2-purinergic agonist in the myocardium. Physiol Rev 81:767-806
2. Sawynok J (1998) Adenosine receptor activation and nociception. Eur J Pharmacol 347:1-11
3. Bours MJ, Swennen EL, Di Virgilio F (2006) Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 112:358-404
4. Burnstock G (2007) Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87:659-797
5. Gordon JL (1986) Extracellular ATP: Effects, sources and fate. Biochem J 233:309-319
6. Dubyak GR (1991) Signal transduction by P2-purinergic receptors for extracellular ATP. Am J Respir Cell Mol Biol 4:295-300
7. Boeynaems JM, Communi D, Gonzalez NS (2005) Overview of the P2 receptors. Semin Thromb Hemost 31:139-149
8. North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013-1067
9. Burnstock G (2007) Purine and pyrimidine receptors. Cell Mol Life Sci 64:1471-1483
10. Schneider EM, Vorlaender K, Ma X (2006) Role of ATP in trauma-associated cytokine release and apoptosis by P2X7 ion channel stimulation. Ann N Y Acad Sci 1090:245-252
11. Dell'Antonio G, Quattrini A, Cin ED (2002) Relief of inflammatory pain in rats by local use of the selective P2X7 ATP receptor inhibitor, oxidized ATP. Arthritis Rheum 46:3378-3385
12. Labasi JM, Petrushova N, Donovan C (2002) Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 168:6436-6445
13. Nino-Moreno P, Portales-Perez D, Hernandez-Castro B (2007) P2X7 and NRAMP1/SLC11 A1 gene polymorphisms in Mexican mestizo patients with pulmonary tuberculosis. Clin Exp Immunol 148:469-477
14. Fernando SL, Saunders BM, Sluyter R (2007) A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis. Am J Respir Crit Care Med 175:360-366
15. Mizuno K, Okamoto H, Horio T (2001) Heightened ability of monocytes from sarcoidosis patients to form multi-nucleated giant cells in vitro by supernatants of concanavalin A-stimulated mononuclear cells. Clin Exp Immunol 126:151-156
16. Parvathenani LK, Tertyshnikova S, Greco CR (2003) P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J Biol Chem 278:13309-13317
17. Hu Y, Fisette PL, Denlinger LC (1998) Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. J Biol Chem 273:27170-27175
18. Guerra AN, Fisette PL, Pfeiffer ZA (2003) Purinergic receptor regulation of LPS-induced signaling and pathophysiology. J Endotoxin Res 9:256-263
19. Ferrari D, Pizzirani C, Adinolfi E (2006) The P2X7 receptor: A key player in IL-1 processing and release. J Immunol 176:3877-3883
20. Hewinson J, Mackenzie AB (2007) P2X(7) receptor-mediated reactive oxygen and nitrogen species formation: From receptor to generators. Biochem Soc Trans 35:1168-1170
21. Pfeiffer ZA, Guerra AN, Hill LM (2007) Nucleotide receptor signaling in murine macrophages is linked to reactive oxygen species generation. Free Radic Biol Med 42:1506-1516
22. Pfeiffer ZA, Aga M, Prabhu U (2004) The nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho. J Leukoc Biol 75:1173-1182
23. Denlinger LC, Fisette PL, Garis KA (1996) Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem 271:337-342
24. Di Virgilio F, Falzoni S, Chiozzi P (1999) ATP receptors and giant cell formation. J Leukoc Biol 66:723-726
25. Baricordi OR, Melchiorri L, Adinolfi E (1999) Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP receptor. J Biol Chem 274:33206-33208
26. Mackenzie AB, Young MT, Adinolfi E (2005) Pseudoapoptosis induced by brief activation of ATP-gated P2X7 receptors. J Biol Chem 280:33968-33976
27. Darville T, Welter-Stahl L, Cruz C (2007) Effect of the purinergic receptor P2X7 on Chlamydia infection in cervical epithelial cells and vaginally infected mice. J Immunol 179:3707-30714
28. Li CM, Campbell SJ, Kumararatne DS (2002) Association of a polymorphism in the P2X7 gene with tuberculosis in a Gambian population. J Infect Dis 186:1458-1462
29. Barden N, Harvey M, Gagne B (2006) Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet 141:374-382
30. Smart ML, Gu B, Panchal RG (2003) P2X7 receptor cell surface expression and cytolytic pore formation are regulated by a distal C-terminal region. J Biol Chem 278:8853-8860
31. Denlinger LC, Fisette PL, Sommer JA (2001) Cutting edge: The nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J Immunol 167:1871-1876
32. Gu BJ, Zhang W, Worthington RA (2001) A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. J Biol Chem 276:11135-11142
33. Li CM, Campbell SJ, Kumararatne DS (2002) Response heterogeneity of human macrophages to ATP is associated with P2X7 receptor expression but not to polymorphisms in the P2RX7 promoter. FEBS Lett 531:127-131
34. Wiley JS, Dao-Ung LP, Li C (2003) An Ile-568 to Asn polymorphism prevents normal trafficking and function of the human P2X7 receptor. J Biol Chem 278:17108-17113
35. Gu BJ, Sluyter R, Skarratt KK (2004) An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor. J Biol Chem 279:31287-31295
36. Le Stunff H, Auger R, Kanellopoulos J (2004) The Pro-451 to Leu polymorphism within the C-terminal tail of P2X7 receptor impairs cell death but not phospholipase D activation in murine thymocytes. J Biol Chem 279:16918-16926
37. Cabrini G, Falzoni S, Forchap SL (2005) A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. J Immunol 175:82-89
38. Skarratt KK, Fuller SJ, Sluyter R (2005) A 5′ intronic splice site polymorphism leads to a null allele of the P2X7 gene in 1-2% of the Caucasian population. FEBS Lett 579:2675-2678
39. Shemon AN, Sluyter R, Fernando SL (2006) A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages. J Biol Chem 281:2079-2086
40. Denlinger LC, Angelini G, Schell K (2005) Detection of human P2X7 nucleotide receptor polymorphisms by a novel monocyte pore assay predictive of alterations in lipopolysaccharide-induced cytokine production. J Immunol 174:4424-4431
41. Denlinger LC, Coursin DB, Schell K (2006) Human P2X7 pore function predicts allele linkage disequilibrium. Clin Chem 52:995-1004
42. Sjoblom T, Jones S, Wood LD (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314:268-274
43. Slater M, Danieletto S, Gidley-Baird A (2004) Early prostate cancer detected using expression of non-functional cytolytic P2X7 receptors. Histopathology 44:206-215
44. Solini A, Cuccato S, Ferrari D (2008) Increased P2X7 receptor expression and function in thyroid papillary cancer: A new potential marker of the disease. Endocrinol 149:389-396
45. Li X, Zhou L, Feng YH (2006) The P2X7 receptor: A novel biomarker of uterine epithelial cancers. Cancer Epidemiol Biomarkers Prev 15:1906-1913
46. Zhang XJ, Zheng GG, Ma XT (2004) Expression of P2X7 in human hematopoietic cell lines and leukemia patients. Leuk Res 28:1313-1322
47. Li X, Qi X, Zhou L (2007) Decreased expression of P2X7 in endometrial epithelial pre-cancerous and cancer cells. Gynecol Oncol 106:233-243
48. Feng YH, Li X, Wang L (2006) A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization. J Biol Chem 281:17228-17237
49. Di Virgilio F, Chiozzi P, Ferrari D (2001) Nucleotide receptors: An emerging family of regulatory molecules in blood cells. Blood 97:587-600
50. Watters J, Sommer J, Fisette P (2001) P2X7 nucleotide receptor: modulation of LPS-induced macrophage signaling and mediator production. Drug Dev Res 53:91-104
51. Lister MF, Sharkey J, Sawatzky DA (2007) The role of the purinergic P2X7 receptor in inflammation. J Inflamm 4:5
52. Noguchi T, Ishii K, Fukutomi H (2008) Requirement of reactive oxygen species-dependent activation of ASK1-p38 MAPK pathway for extracellular ATP-induced apoptosis in macrophage. J Biol Chem 283:7657-7665
53. Suh BC, Kim JS, Namgung U (2001) P2X7 nucleotide receptor mediation of membrane pore formation and superoxide generation in human promyelocytes and neutrophils. J Immunol 166:6754-6763
54. Di Virgilio F, Chiozzi P, Falzoni S (1998) Cytolytic P2X purinoceptors. Cell Death Differ 5:191-199
55. Stefano L, Rossler OG, Griesemer D (2007) P2X(7) receptor stimulation upregulates Egr-1 biosynthesis involving a cytosolic Ca(2+) rise, transactivation of the EGF receptor and phosphorylation of ERK and Elk-1. J Cell Physiol 213:36-44
56. Guerra AN, Gavala ML, Chung HS (2007) Nucleotide receptor signalling and the generation of reactive oxygen species. Purinergic Signal 3:39-51
57. Denu JM, Tanner KG (1998) Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: Evidence for a sulfenic acid intermediate and implications for redox regulation. Biochem 37:5633-5642
58. Guyton KZ, Liu Y, Gorospe M (1996) Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem 271:4138-4142
59. Iles KE, Dickinson DA, Watanabe N (2002) AP-1 activation through endogenous H(2)O(2) generation by alveolar macrophages. Free Radic Biol Med 32:1304-1313
60. Kaul N, Forman HJ (1996) Activation of NF kappa B by the respiratory burst of macrophages. Free Radic Biol Med 21:401-405
61. Lander HM (1997) An essential role for free radicals and derived species in signal transduction. FASEB J 11:118-124
62. Lee K, Esselman WJ (2002) Inhibition of PTPs by H(2)O(2) regulates the activation of distinct MAPK pathways. Free Radic Biol Med 33:1121-1132
63. Lo YY, Wong JM, Cruz TF (1996) Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J Biol Chem 271:15703-15707
64. Curtin JF, Donovan M, Cotter TG (2002) Regulation and measurement of oxidative stress in apoptosis. J Immunol Methods 265:49-72
65. Pines A, Perrone L, Bivi N (2005) Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP. Nucleic Acids Res 33:4379-4394
66. Adler V, Yin Z, Tew KD (1999) Role of redox potential and reactive oxygen species in stress signaling. Oncogene 18:6104-6111
67. Ferrari D, Wesselborg S, Bauer MK (1997) Extracellular ATP activates transcription factor NF-kappaB through the P2Z purinoreceptor by selectively targeting NF-kappaB p65. J Cell Biol 139:1635-1643
68. Aga M, Watters JJ, Pfeiffer ZA (2004) Evidence for nucleotide receptor modulation of cross talk between MAP kinase and NF-kappa B signaling pathways in murine RAW 264.7 macrophages. Am J Physiol Cell Physiol 286:C923-C930
69. Aga MJ, Johnson CJ, Hart AP (2002) Modulation of monocytes signaling and pore formation in response to agonists of the nucleotide receptor P2X7. J Leukoc Biol 72:222-232
70. Di Virgilio F (1995) The P2Z purinoceptor: An intriguing role in immunity, inflammation and cell death. Immunol Today 16:524-528
71. Ferrari D, Chiozzi P, Falzoni S (1997) ATP-mediated cytotoxicity in microglial cells. Neuropharmacology 36:1295-1301
72. Grahames CB, Michel AD, Chessell IP (1999) Pharmacological characterization of ATP- and LPS-induced IL-1beta release in human monocytes. Br J Pharmacol 127:1915-1921
73. Griffiths RJ, Stam EJ, Downs JT (1995) ATP induces the release of IL-1 from LPS-primed cells in vivo. J Immunol 154:2821-2828
74. Solle M, Labasi J, Perregaux DG (2001) Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 276:125-132
75. Tonetti M, Sturla L, Bistolfi T (1994) Extracellular ATP potentiates nitric oxide synthase expression induced by lipopolysaccharide in RAW 264.7 murine macrophages. Biochem Biophys Res Commun 203:430-435
76. Tonetti M, Sturla L, Giovine M (1995) Extracellular ATP enhances mRNA levels of nitric oxide synthase and TNF-alpha in lipopolysaccharide-treated RAW 264.7 murine macrophages. Biochem Biophys Res Commun 214:125-130
77. Cassatella MA, Bazzoni F, Flynn RM (1990) Molecular basis of interferon-gamma and lipopolysaccharide enhancement of phagocyte respiratory burst capability. Studies on the gene expression of several NADPH oxidase components. J Biol Chem 265:20241-20246
78. Quinn MT, Gauss KA (2004) Structure and regulation of the neutrophil respiratory burst oxidase: Comparison with nonphagocyte oxidases. J Leukoc Biol 76:760-781
79. Sheppard FR, Kelher MR, Moore EE (2005) Structural organization of the neutrophil NADPH oxidase: Phosphorylation and translocation during priming and activation. J Leukoc Biol 78:1025-1042
80. DeLeo FR, Renee J, McCormick S (1998) Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly. J Clin Invest 101:455-463
81. Vignais PV (2002) The superoxide-generating NADPH oxidase: Structural aspects and activation mechanism. Cell Mol Life Sci 59:1428-1459
82. Decoursey TE, Ligeti E (2005) Regulation and termination of NADPH oxidase activity. Cell Mol Life Sci 62:2173-2193
83. Groemping Y, Rittinger K (2005) Activation and assembly of the NADPH oxidase: A structural perspective. Biochem J 386:401-416
84. Budagian V, Bulanova E, Brovko L (2003) Signaling through P2X7 receptor in human T cells involves p56lck, MAP kinases, and transcription factors AP-1 and NF-kappa B. J Biol Chem 278:1549-1560
85. Armstrong S, Korcok J, Sims SM (2007) Activation of transcription factors by extracellular nucleotides in immune and related cell types. Purinergic Signal 3:59-69
86. Franco-Martinez S, Nino-Moreno P, Bernal-Silva S (2006) Expression and function of the purinergic receptor P2X7 in patients with pulmonary tuberculosis. Clin Exp Immunol 146:253-261
87. Shaywitz AJ, Greenberg ME (1999) CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 68:821-861
88. Mayr B, Montminy M (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2:599-609
89. Potucek YD, Crain JM, Watters JJ (2006) Purinergic receptors modulate MAP kinases and transcription factors that control microglial inflammatory gene expression. Neurochem Int 49:204-214
90. Desmet C, Gosset P, Henry E (2005) Treatment of experimental asthma by decoy-mediated local inhibition of activator protein-1. Am J Respir Crit Care Med 172:671-678
91. Guo RF, Lentsch AB, Sarma JV (2002) Activator protein-1 activation in acute lung injury. Am J Pathol 161:275-282
92. Padeh S, Cohen A, Roifman CM (1991) ATP-induced activation of human B-lymphocytes via P2-purinoceptors. J Immunol 146:1626-1632
93. John GR, Simpson JE, Woodroofe MN (2001) Extracellular nucleotides differentially regulate interleukin-1beta signaling in primary human astrocytes: Implications for inflammatory gene expression. J Neurosci 21:4134-4142
94. Liu JS, John GR, Sikora A (2000) Modulation of interleukin-1beta and tumor necrosis factor alpha signaling by P2 purinergic receptors in human fetal astrocytes. J Neurosci 20:5292-5299
95. Humphreys BD, Rice J, Kertesy SB (2000) Stress-activated protein kinase/ JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor. J Biol Chem 275:26792-26798
96. Denlinger LC, Sommer JA, Parker K (2003) Mutation of a dibasic amino acid motif within the C terminus of the P2X7 nucleotide receptor results in trafficking defects and impaired function. J Immunol 171:1304-1311
97. Fernando SL, Saunders BM, Sluyter R (2005) Gene dosage determines the negative effects of polymorphic alleles of the P2X7 receptor on adenosine triphosphate-mediated killing of mycobacteria by human macrophages. J Infect Dis 192:149-155
98. Michelsen K, Yuan H, Schwappach B (2005) Hide and run. Arginine-based endoplasmic-reticulum-sorting motifs in the assembly of heteromultimeric membrane proteins. EMBO Rep 6:717-722
99. Margeta-Mitrovic M, Jan YN, Jan LY (2000) A trafficking checkpoint controls GABA(B) receptor heterodimerization. Neuron 27:97-106
100. Standley S, Roche KW, McCallum J (2000) PDZ domain suppression of an ER retention signal in NMDA receptor NR1 splice variants. Neuron 28:887-898
101. Schutze MP, Peterson PA, Jackson MR (1994) An N-terminal double-arginine motif maintains type II membrane proteins in the endoplasmic reticulum. EMBO J 13:1696-1705
102. Zerangue N, Schwappach B, Jan YN (1999) A new ER trafficking signal regulates the subunit stoichiometry of plasma membrane K(ATP) channels. Neuron 22:537-548
103. Ren Z, Riley NJ, Needleman LA (2003) Cell surface expression of GluR5 kainate receptors is regulated by an endoplasmic reticulum retention signal. J Biol Chem 278:52700-52709
104. Hou JC, Pessin JE (2007) Ins (endocytosis) and outs (exocytosis) of GLUT4 trafficking. Curr Opin Cell Biol 19:466-473
105. Korpi-Steiner NL, Bates ME, Lee WM (2006) Human rhinovirus induces robust IP-10 release by monocytic cells, which is independent of viral replication but linked to type I interferon receptor ligation and STAT1 activation. J Leukoc Biol 80:1364-1374